Last reviewed · How we verify

NCT04700254

Anxiety, Depression and Eating Attitudes of Diabetes Mellitus Patients During COVID-19 Lockdown in Greece

Completed Last updated 25 January 2021
What this trial tests

trial testing DASS questionnaire in Diabetes Mellitus in 150 participants. Completed in 11 January 2021.

Timeline
28 December 2020
Primary endpoint
11 January 2021
11 January 2021

Quick facts

Lead sponsorChania General Hospital "St. George"
StatusCompleted
Study typeOBSERVATIONAL
Enrollment150
Start date28 December 2020
Primary completion11 January 2021
Estimated completion11 January 2021
Sites1 location across Greece

Drugs / interventions tested

Conditions studied

Sponsor

Chania General Hospital "St. George"

Who can join

Adults 18 to 85, any sex, with Diabetes Mellitus or SARS-CoV-2. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this observational, cross-sectional study is to evaluate the impact of the second national COVID-19 lockdown in Greece, regarding the aspects of depression, anxiety and eating habits, in relation to the adjusted work and family conditions, among diabetes mellitus patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The Impact of Government Lockdowns on the Mental Health of the General Population: A Systematic Review and Meta-analysis.
    Okazaki Y, Tsujimoto Y, Yamada K, Saka N, et al · · 2025 · PMID 40453305 · DOI 10.7759/cureus.83249

Verify or expand the search:

Other recruiting trials for Diabetes Mellitus

Currently open trials in the same condition.

Other Chania General Hospital "St. George" trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04700254.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing